Cardiac Natriuretic Peptides in Heart Failure

References

• de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981; 28: 89–94.
   PubMed Web of Science ®Google Scholar
• Nakao K, Ogawa Y, Suga S, Imura H. Molecular biology and biochemistry of the natriuretic peptide system. II. Natriuretic peptide receptors. J Hypertens 1992; 10: 1111–4.
   PubMed Web of Science ®Google Scholar
• Richards AM, McDonald D, Fitzpatrick MA, et al. Atrial natriuretic hormone has biological effects in man at physiological plasma concentrations. J Clin Endocrinol Metab 1988; 67: 1134–9.
   PubMed Web of Science ®Google Scholar
• Janssen WMT, de Zeeuw D, van der Hem GK, de Jong PE. Antihypertensive effect of a 5-day infusion of atrial natriuretic factor in humans. Hypertension 1989; 13: 640–6.
   PubMed Web of Science ®Google Scholar
• Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest 1991; 87: 1402–12.
   PubMed Web of Science ®Google Scholar
• Suga S, Nakao K, Hosoda K, et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 1992; 130: 229–39.
   PubMed Web of Science ®Google Scholar
• Holmes SJ, Espiner EA, Richards AM, Yandle TG, Frampton C. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab 1993; 76: 91–6.
   PubMed Web of Science ®Google Scholar
• Sugawara A, Nakao K, Morii N, et al. Synthesis of atrial natriuretic polypeptide in human failing hearts. J Clin Invest 1988; 81: 1962–70.
   PubMed Web of Science ®Google Scholar
• Togashi K, Kameya T, Ando K, Marumo F, Kawakami M. Brain natriuretic peptides in human plasma, spinal cord and cerebrospinal fluid. Clin Chim Acta 1991; 201: 193–200.
   PubMed Web of Science ®Google Scholar
• Crozier IG, Nicholls MG, Ikram H, Espiner EA, Gomez HJ, Warner NJ. Haemodynamic effects of atrial peptide infusion in heart failure. Lancet 1986; 2: 1242–5.
   PubMed Web of Science ®Google Scholar
• Dubois-Rande JL, Adnot S, Benvenuti C, et al. Hemodynamic response to intracoronary infusion of atrial natriuretic factor in patients with normal or altered left ventricular function. J Cardiovasc Pharmacol 1991; 17: 608–14.
   PubMed Web of Science ®Google Scholar
• Yoshimura M, Yasue H, Morita E, et al. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 1991; 84: 1581–8.
   PubMed Web of Science ®Google Scholar
• Hoffman A, Grossman E, Keiser HR. Increased plasma levels and blunted effects of brain natriuretic peptide in rats with congestive heart failure. Am J Hypertens 1991; 4: 597–601.
   PubMed Web of Science ®Google Scholar
• Lee ME, Miller WL, Edwards BS, Burnett JC. Role of endogenous atrial natriuretic factor in acute congestive heart failure. J Clin Invest 1989; 84: 1962–6.
   PubMed Web of Science ®Google Scholar
• Wilkins MR, Settle SL, Stockmann PT, Needleman P. Maximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failure. Proc Natl Acad Sci USA 1990; 87: 6465–9.
   PubMed Web of Science ®Google Scholar
• Wilkins MR, Settle SL, Kirk JE, Taylor SA, Moore KP, Unwin RJ. Response to atrial natriuretic peptide, endo-peptidase 24.11 inhibitor and C-ANP receptor ligand in the rat. Br J Pharmacol 1992; 107: 50–7.
   PubMed Web of Science ®Google Scholar
• Eisner D, Muntze A, Kromer EP, Riegger GAJ. Effectiveness of endopeptidase inhibition (Candoxatril) in congestive heart failure. Am J Cardiol 1992; 70: 494–8.
   PubMed Web of Science ®Google Scholar
• Munzel T, Kurz S, Holtz J, et al. Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure. Circulation 1992; 86: 1089–98.
   PubMed Web of Science ®Google Scholar
• Drexler H, Hirth C, Stasch HP, Lu W, Neuser D, Just H. Vasodilatory action of endogenous atrial natriuretic factor in a rat model of chronic heart failure as determined by monoclonal ANF antibody. Circ Res 1990; 66: 1371–80.
   PubMed Web of Science ®Google Scholar
• Awazu M, Imada T, Kon V, Inagami T, Ichikawa I. Role of endogenous atrial natriuretic peptide in congestive heart failure. Am J Physiol 1989; 257: R641–R646.
   PubMedGoogle Scholar
• Wada A, Kanamori T, Maeda Y, Tsutamoto T, Kinoshlta M. Pathophysiological role of endogenous atrial natriuretic peptide in severe congestive heart failure. J Am Coll Cardiol 1993; 21: 314A.
   Google Scholar
• Mukoyama M, Nakao K, Obata K, et al. Augmented secretion of brain natriuretic peptide in acute myocardial infarction. Biochem Biophys Res Commun 1991; 180: 431–6.
   PubMed Web of Science ®Google Scholar
• Sussex BA, Arnold JMO, Parker JO, et al. Independent and interactive prognostic information of neurohormones and echocardiogram in high risk post-MI patients. J Am Coll Cardiol 1992; 19: 205A.
   PubMedGoogle Scholar
• Davis KM, Fish LC, Elahi D, Clark BA, Minaker KL. Atrial natriuretic peptide levels in the prediction of congestive heart failure risk in frail elderly. JAMA 1992; 267: 2625–9.
   PubMed Web of Science ®Google Scholar